Relistor 8 mg/.4mL
Methylnaltrexone bromide · INJECTION, SOLUTION · Salix Pharmaceuticals, Inc.
Relistor is a injection, solution containing methylnaltrexone bromide at 8 mg/.4mL, taken subcutaneous. Manufactured by Salix Pharmaceuticals, Inc..
Key Facts
- Brand Name
- Relistor
- Generic Name
- Methylnaltrexone bromide
- NDC Code (Product)
65649-552- Manufacturer
- Salix Pharmaceuticals, Inc.
- Strength
- 8 mg/.4mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA021964
- Marketing Start
- 04/24/2008
Recall History
No Recall HistoryFrequently Asked Questions
What is Relistor used for?
Relistor contains Methylnaltrexone bromide. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Relistor a controlled substance?
Relistor is not classified as a controlled substance by the DEA.
What is the generic name for Relistor?
The generic name for Relistor is Methylnaltrexone bromide. There are no other listed brand versions of Methylnaltrexone bromide.
What is the NDC code for Relistor 8 mg/.4mL?
The NDC (National Drug Code) for Relistor 8 mg/.4mL is 65649-552, listed by Salix Pharmaceuticals, Inc..
Other Relistor Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)